Consenso - Associação Brasileira de Alergia e Imunopatologia

More documents

Recommendations

Info

54 Rev. bras. alerg. imunopatol. – Vol. 29, Nº 1, 2006 Consenso alterar a fisiologia nasal, provocar dor retro-ocular em por com temperatura baixa, formar crostas persis- ambientes e rinite seca. Ela deve ser restrita a casos de cirurtentes para ressecção de tumores. gia infiltração de corticosteróide nas conchas nasais vem A desencorajada, pois seu efeito é fugaz e também há sendo relatos de trombose da artéria central da retina. ADERÊNCIA AO TRATAMENTO 8. muita freqüência os pacientes que sofrem de rinite Com abandonam seus tratamentos após curto período alérgica tempo. Trata-se de doença, que apesar de crônica, ca- de por sintomas de leve intensidade perfeitamenracteriza-se suportáveis pelos pacientes, sendo bastante subestimate por todos: médicos, pacientes e familiares. Entretanto, da conseqüências a médio e longo prazo, em relação às suas e à queda na qualidade vida, podem ser de- complicações ao paciente. sastrosas boa aderência ao tratamento corresponde a uma par- A ativa do paciente à prescrição médica, e não poticipação deixar de destacar que, segundo alguns estudiosos demos área, a prescrição médica não é apenas a receita médi- da mas sim todo o esclarecimento, orientações e a escolha ca, medicamento mais adequado. do aderência ao tratamento está intimamente relacionada A diversos fatores como: idade; sexo; estado nutricional; a genético; nível socioeconômico; apresentação patrimônio medicamento; posologia, características fisico-químicas; do colaterais; gravidade da doença; enfim, uma ampla efeitos complexa interação entre diversos aspectos da doença, e droga e do paciente. Porém, não podemos deixar de da que o sucesso da aderência ao tratamento de uma lembrar crônica como a rinite alérgica relaciona-se, funda- doença com boa relação médico-paciente. mentalmente, 9. REFERÊNCIAS Intra-nasal steroids and the risk of emergency department 1. for asthma. J Allergy Clin Immunol 2002; 109:636-42. visits Alaranta A, Alaranta H, Heliovaara M, Alha P, Palmu P, Hele- 2. I. Allergic rhinitis and pharmacological management in nius athletes. Méd Sci Sports Exerc 2005; 37: 707-711. elite Allen DB, Meltzer EO, Lemanske RF, Jr., Philpot EE, Faris MA, 3. KM et al. No growth suppression in children treated with Kral maximum recommended dose of fluticasone propionate the nasal spray for one year. Allergy Asthma Proc 2002; aqueous 407-13. 23: Allen DB. Systemic effects of intranasal steroids: An endocri- 4. perspective. J Allergy Clin Immunol 2000; 106: nologist’s S179-90. Araújo E, Sakano E, Weckx L. Consenso Brasileiro Sobre 5. Rev Bras Otorrinolaringol 1999; 65: supl. 9. Rinossinusite. Arruda LK, Rizzo, Chapman MD, Fernandez-Caldas E, Bagg 6. Platts Mills TA et al. Exposure and Sensitization to Dust D, Allergens Among Asthmatic Children in São Paulo, Mite Clin Exper Allergy 1991; 21: 433-439. Brazil. Aubier M, Neukirch C, Peiffer C, Melac M. Effect of cetirizine 7. bronchial hyperresponsiveness in patients with seasonal on rhinitis and asthma. Allergy 2001; 56:35-42. allergic Aun WT, Nunes IC, Aun VV. Antihistamínicos. In: Castro FFM 8. Rinite alérgica: modernas abordagens para uma clássi- (ed). questão, 3ª ed, São Paulo: Vivali Editora, 2003; p.97-111. ca Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, 9. J et al. Levocetirizine improves quality of life and redu- Mullol costs in long term management of persistent allergic rhices J Allergy Clin Immunol 2004; 114: 838-44. nitis. Baena-Cagnani CE, Berger WE, Dubuske LM, Gurne SE, 10. P, Lorber R et al. Comparative effects of deslorata- Stryszak versus montelukast on asthma symptoms and use of dine 2-agonists in patients with seasonal allergic rhinitis and beta Int Arch Allergy Immunol 2003; 130: 307-13. asthma. Baroody FM, Suh SH, Naclerio RM. Total IgE serum levels 11. with sinus mucosal thickness on computerized to- correlate mography scans. J Allergy Clin Immunol 1997; 100:563-8. Baumann I, Plinkert PK. Effect of Breathing Mode and Nose 12. on Growth of the Facial Bones. HNO 1996; 44 (5): Ventilation 229-34. Benninger MS, Holtzer SE, Lan J. Diagnosis and treatment of 13. acute bacterial rhinosinusitis: summary of the uncomplicated for Health Care Policy and Research evidence-based Agency Otolaryngol Head Neck Surg 2000; 122: 1-7. report. Bernd LAG, Baggio D, Becker AB, Ambrozio LC. Identificação 14. Estudo da Atividade Sensibilizante de Ácaros Domésticos e Porto Alegre (RS). Rev. bras. alerg. imunopatol. 1994; em 23-33. 17: Besancon-Watelet C, Bene MC, Montagne P, Faure GC, Jan- 15. R. Eosinophilia and cell activation mediators in nasal kowski Laryngoscope 2002; 112 (1): 43-46. secretions. Bousquet J, Cauwenberge P, Khaltaev N, ARIA Workshop 16. World Health Organization. Allergic rhinitis and its Group, on asthma. J Allergy Clin Immunol 2001; 108: S147- impact S334. Bousquet J, Lockey R, Malling H. WHO Position Paper, Aller- 17. immunotherapy: therapeutic vaccines for allergic diseagen Allergy 1998; 53 (Suppl 44). ses. Bousquet J, Michel FB. Specific immunotherapy in allergic rhi- 18. and asthma. In: Busse W.W & Holgate ST, ed. Asthma nitis rhinitis. England: Blackwell Scientific Publications, 1995; and 1309-1324. Bousquet J, van Cauwenberge P, Khaltaev N (WHO) and the 19. expert panel. Allergic rhinitis and its impact on as- workshop (ARIA). Allergy 2002; 57: 841-855. thma Bousquet J, Van Cauwenberge P, Khaltaev N. ARIA in the 20. management of allergic rhinitis symptoms in the pharmacy: Allergic Rhinitis and its Impact on Asthma. Aller- pharmacy. 2004; 59:4, 373-387. gy Braga CR, Rizzo MC, Naspitz CK, Sole D. Nasal provocation 21. (NPT) with isolated and associated Dermatophagoides test (Dp) and endotoxin lipopolysaccharide (LPS) in pteronyssinus with allergic rhinitis (AR) and nonallergic controls. J children Allergol Clin Immunol 2004;14: 142-8. Investig Braunstahl GJ, Kleinjan A, Overbeek S, Prins JB, Hoogsteden 22. Fokkens W. Segmental bronchial provocation induces na- H, inflammation in allergic rhinitis patients. Am J Respir Crit sal Med 2000; 161:2051-7. Care Bresciani M, Paradise L, Des Roches A, Vernhet H, Vachier I, 23. P et al. Rhinosinusitis in severe asthma. J Allergy Clin Godard 2001;107: 73-80. Immunol. Brinke A, Grootendorst DC, Schmidt JT, Bruïne FT, van Bu- 24. RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. chem MA, Adams PJ et al. Chronic sinusitis in severe asthma is related to Sterk eosinophilia. J Allergy Clin Immunol 2002; 109: 621- sputum 6. Camargos PAM, Rodrigues MESM, Lasmar LMLBF. Simulta- 25. Treatment of Asthma and Allergic Rhinitis. Pediatr Pulneous 2004; 38: 1–7. monol Casale TB. Status of immunotherapy: current and future. J 26. Clin Immunol 2004; 113: 1036-1039. Allergy Church MK. Histamine receptors, inverse agonism, and aller- 27. Allergy Clin Immunol Int – J WAO 2004; 16: 112-116. gy. Ciprandi G, Canonica WG, Grosclaude M, Ostinelli J, Brazzola 28. Bousquet J. Effects of budesonide and fluticasone propio- GG, in a placebo-controlled study on symptoms and quality nate life in seasonal allergic rhinitis. Allergy 2002; 57: 586-91. of Ciprandi G, Marseglia GL, Klersy C, Tosca MA.- Relationships 29. allergic inflammation and nasal airflow in children between persistent allergic rhinitis due to mite sensitization. with 2005 Jul;60(7):957-60 Allergy. Ciprandi G, Tosca M, Passalacqua G, Canonica GW. Long- 30. cetirizine treatment reduces allergic symptoms and term prescriptions in children with mite allergy. Ann Allergy drug Immunol 2001; 87: 222-6. Asthma Consenso sobre rinites. Rev Bras Otorrinolaringol 2000; 66: 31. 1-34. Contencin P, Gumpert L, Sleiman J, Possel L, De Gaudemar I, 32. C. Nasal Fossae Dimensions in the Neonate and Adamsbaum Infant: A Computed Tomographic Scan Study. Arch Young Head Neck Surg 1999; 125(7): 777-81. Otolaryngol Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. 33. therapy and the prevention of hospital care for asth- Rhinitis a case-control study. J Allergy Clin Immunol 2004;113: ma: 415-9. Corren J. Intranasal corticosteroids for allergic rhinitis: How 34. different agents compare? J Allergy Clin Immunol 1999; do 104:S144-9.
Consenso Rev. bras. alerg. imunopatol. – Vol. 29, Nº 1, 2006 55 Craig TJ, McCann L, Gurevich F, Davies MJ. The correlation 35. allergic rhinitis and sleep disturbance. J Allergy Clin between 2004; 114: S139-S145. Immunol Creticos PS. Immunotherapy of allergic diseases. In: Rich RR, 36. TA, Schwartz BD, Shearer WT, Strober W, ed. Clini- Fleisher Immunology, Principles and Practice, Mosby, 1996; 2002- cal 2018. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating 37. rhinitis in patients with comorbid asthma: The risk of allergic related hospitalizations and emergency depar-tment asthma J Allergy Clin Immunol 2002; 109: 57-62. visits. Des Roches A, Paradise L, Ménardo JL, Bouges S, Daurès JP, 38. J. Immunotherapy with standardized Dermatopha- Bousquet pteronyssinus extract. VI. Specific immunotherapy goides the onset of new sensitizations in children. J Allergy prevents Immunol 1997; 99: 450-453. Clin Di Lorenzo G, Pacor Ml, Pellitteri ME, Morici G, Di Gregoli A, 39. Bianco C, et al. Randomized placebo-controlled trial com- Lo fluticasone aqueous nasal spray in mono-therapy, paring plus cetirizine, fluticasone plus montelukast and fluticasone plus montelukast for seasonal allergic rhinitis. Clin cetirizine Allergy 2004; 34: 259-67. Exp Dykewicz MS, Fineman S, Skoner DP. Diagnosis and mana- 40. of rhinitis: complete guidelines of the Joint Task Forgement on Practice Parameters in allergy, asthma and immunoloce Ann Allergy Asthma Immunol 1998; 81: 478-518. gy. Ellegard EK, Hellgren M, Karlsson NG. Fluticasone propionate 41. nasal spray in pregnancy rhinitis. Clin Otolaryngol aqueous 26: 394-400. 2001; Elwany S, Harrison R. Inferior Turbinectomy: Comparission of 42. Techniques. J Laryngol Otol 1990; 104: 206-209. our Emanuel I, Shah S. Chronic rhinosinusitis: allergy and sinus 43. tomography relationships. Otolaryngol Head Neck computed 2000; 123: 687-91. Surg Esteves PC, Rosário Fº NA, Trippia SG, Caleffe LG. Prevalên- 44. de rinite alérgica perene e sazonal, com sensibilização cia ao Dermatophagoides pteronyssinus (Dp) e ao Lolium atópica (LOLIUM) em escolares de 13 e 14 anos e adul- multiflorum de Curitiba. Rev Bras Alerg Imunopatol 2000; 23:249- tos 259. Executive Committee, American Academy of Allergy Asthma 45. Immunology. Guidelines to Minimize the Risk from Syste- & Reactions Caused by Immunotherapy with Allergenic mic (Position Statement). J Allergy Clin Immunol 1994; Extracts (4): 811-812. 93 Fiocchi A, Pajno G, La Grutta S, Pezzuto F, Incorvaia C, Sensi 46. et al. Safety of sublingual-swallow immuno-therapy in L, aged 3 to 7 years. Ann Allergy Asthma Immunol children 95: 254-8. 2005; Fireman P. Otitis media and Eustachian tube dysfunction: 47. to allergic rhinitis. J Allergy Clin Immunol 1997; conection S787-97. 99: Fokkens W, Lund V, Bachert C. EAACI Position paper on 48. and nasal polyps executive summary. Allergy rhinosinusitis 60: 583-601. 2005; Francesco RC, Passeroti G, Paulucci BE, Miniti A. Respiração 49. na criança: repercussões diferentes de acordo com o oral - Rev Bras Otorrinolaringol 2004; 70: 665-70. diagnóstico Galvão CES, Saldiva PH. Rinite Alérgica e Poluição Ambiental. 50. Castro FFM. Rinite Alérgica Modernas Abordagens para In: Clássica Questão. São Paulo: Lemos Editorial, 1997. uma Gawchik S, Goldstein S, Prenner B, John A. Relief of cough 51. nasal symptoms associated with allergic rhinitis by mo- and furoate nasal spray. Ann Allergy Asthma Immunol metasone 90: 416-21. 2003; Gobbo JF, Arteta LM, Rodrigues RP, Andrade JA. Turbinecto- 52. Parcial com Laser CO2; Relato de 29 Casos. Rev Bras mia 1995; 61: 112-113. Otorrinolaringol Gosepath J, Amedee RG, Mann WJ. Nasal provocation tes- 53. as an international standard for evaluation of allergic ting nonallergic Rhinitis. Laryngoscope 2005; 115: 512-16. and Greenberger PA. Use of immunotherapy for allergic disor- 54. diagnostic considerations and indications. Immunol Alders: Clin North Am 1992; 12: 1-12. lergy Guadano EM, Serra-Batlles J, Meseguer J, Castillo JA, Molina 55. Valero A et al. Rupatadine 10 mg and ebastine 10 mg in M, allergic rhinitis: a comparison study. Allergy 2004; seasonal 766-71. 59: Guerra S, Sherrill Dl, Martinez FD, Barbee RA. Rhinitis as an 56. risk factor for adult-onset asthma. J Allergy Clin independent Immunol 2002; 109: 419-25. Gupta S, Banfield C, Kantesaria B, Marino M, Clement R, 57. M et al. Pharmacokinetic and safety profile of deslo- Affrime and fexofenadine when coadministered with aziratadine a randomized, placebo-controlled, parallel-group thromycin: Clin Ther 2001; 23: 451-66. study. Howarth PH. Allergic and nonallergic rhinitis. In: Adkinson 58. Yunginger JW, Busse WW, Bochner BS, Holgate ST, Si- NF, FER, ed. Middleton Principles & Practice, 6 mons th Phila- ed, Pennsyllvania: Mosby, 2003, p.1391-1410. delphia, Hultcrantz E, Larson M, Hellquist R, Ahlquist-Rastad J, Sva- 59. H, Jakobsson OP. The lnfluence of tonsillar obstruction nholm tonsillectomy on facial growth and dental arch morpho- and Int J Ped Otolaringol 1991; 22: 125-34. logy. Iinuma T, Hirota Y, Kase Y. Radio-opacity of the paranasal 60. Conventional views and CT. Rhinology 1994; 32: sinuses. 134-6. Ikino CMY, D’Antonio W, De La Cortina R. Telerradiografia 61. de crânio e radiografia de cavum: estudo comparativo lateral crianças com obstrução nasal. Rev Bras Otorrinolaringol em 66: 592-6. 2000; International Consensus Report On The Diagnosis And Mana- 62. Of Rhinits. International Rhinitis Management Worgement Group. Types of Rhinitis: Eur J Allergy Clin Immunol king 49: 5-34, 1994. 1994; Johansson SG. ImmunoCAP Specific IgE test: an objective 63. for research and routine allergy diagnosis. Exp Rev Mol tool 2004; 4: 273-9. Diagn Johnson IJM, Soames JV, Path FRC, Marshall HF. Nasal Tu- 64. - an Increasing problem?- J Laryngol Otol 1995; berculosis 326-27. 109: Kimmelman CP, Jablonski. The Efficacy of Turbinectomia Sur- 65. for the Relief of Nasal Obstruction. Am. J. Rhinology gery 7: 25-30. 1992; Klautan AA, Ernandes MFM. Rinite Alérgica na Gravidez. Rini- 66. Alérgica Moderna Abordagem para uma Clássica Questão te 16: 205-13. 1997; Klein DE, Settipane RJ. Nasal Polyps. State of the Art. Annals 67. 1991; 11: 33-6. Rhinology Kovalhuk LCS, Rosário Fº NA, Carvalho A. Mediadores infla- 68. citograma em nasal e tomografia computadorizada matórios, seios paranasais em crianças atópicas. J Pediatr (Rio J) de 77: 271-8. 2001; Kovalhuk LCS, Rosario NA, Carvalho A, Cruz AA, Callefe LG. 69. tomographic study of paranasal sinuses and nasal Computed in atopic children without sinusitis symptoms. Pediatr lavage Allergy Immunol 1999; 13(3): 123-131. Asthma Kremer B. Quality of life scales in allergic rhinitis. Curr Opin 70. Clin Immunol 2004; 4: 171-6. Allergy Krouse HJ, Davis JE, Krouse JH. Immune mediators in aller- 71. rhinitis and sleep. Otolaryngol Head Neck Surg 2002; gic 607-613. 126: Kurtz JATA. Presença de Polinose na Região do Planalto Mé- 72. - RGS. Rev Bras Alerg Imunopatol 1998; 21: 196-201. dio Laforce G. Use of Nasal Steroids in Managing Allergic Rhinitis. 73. Allergy Clin Immunol 1999; 103: S388-94. J. Lasleiy MV, Shapiro GG. Rhinitis and Sinusitis in Children. 74. Allergy Clin N America 1999; 19: 437-52. Immunol Lazo-Saenz JG, Galvan-Aguilera AA, Martinez-Ordaz VA, Ve- 75. VM, Nieves-Renteria A, Rincon-Castaneda C. lasco-Rodriguez tube dysfunction in allergic rhinitis. Otolaryngol Eustachian Neck Surg 2005; 132: 626-9. Head Lessa FCR, Enoki C, Feres MFN, Valera FCP, Lima WTA, Mat- 76. MAN. Influência do padrão respiratório na morfologia sumoto Rev Bras Otorrinolaringol 2005; 71: 156-60. craniofacial. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. 77. rhinitis: an independent risk factor for asthma in Perennial subjects. Results from the European Community nonatopic Health Survey. J Allergy Clin Immunol 1999; Respiratory 104:301-4. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. 78. of life in allergic rhinitis and asthma. A population- Quality study of young adults. Am J Respir Crit Care Med -based 2000;162:1391-6. Li JT, Lockey RF, Bernstein IL, Portnoy JM, Nicklas RA. Aller- 79. immunotherapy: a practice parameter. Ann Allergy Asthgen Immunol 2003; 90: 1-40. ma Linneberg A, Henrik Nielsen N, Frolund L, Madsen F, Dirksen 80. et al. The link between allergic rhinitis and allergic A, a prospective population-based study. The Copenha- asthma: Allergy Study. Allergy 2002; 57: 1048-52. gen
Page 1 and 2: 01/29 06/29bras. alerg. imunopatol.
Page 3 and 4: Consenso Rev. bras. alerg. imunopat
Page 25: Consenso Rev. bras. alerg. imunopat

Consenso - Associação Brasileira de Alergia e Imunopatologia

Create successful ePaper yourself

Delete template?

Save as template?